Literature DB >> 2681437

Risk factors for Escherichia coli O157:H7 infection in an urban community.

H E Bryant1, M A Athar, C H Pai.   

Abstract

Outbreaks of Escherichia coli O157:H7 have been attributed to meat or meat products, particularly ground meat, and to unpasteurized dairy products. However, the risk factors for sporadic cases have not been clearly delineated. Study data were collected by using a self-administered dietary and historical questionnaire on all patients whose history included bloody diarrhea and who attended one of the participating emergency departments. Designation as "case" or "control" occurred after stool culture results were known, eliminating the possibility for recall bias common to this type of study. Cases (E. coli O157:H7-positive) were further matched with one diarrheal and one healthy community control, and more detailed information on food preparation practices and other data were then taken. Of 266 presentations of bloody diarrhea, 103 (38.7%) were due to E. coli O157:H7. Unmatched analyses with bloody diarrheal controls revealed a seemingly lower risk for E. coli O157:H7 infection in fast food restaurant patrons. No increased risk could be detected for ground meat consumption despite adequate study power, although an association between ingestion of undercooked meat and infection (odds ratio = 3.5, P less than .05) was found when community controls were used. Proper food cooking (and handling) rather than the avoidance of particular food products is the preventive measure of choice.

Entities:  

Mesh:

Year:  1989        PMID: 2681437     DOI: 10.1093/infdis/160.5.858

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Escherichia coli O157:H7, other verotoxin-producing E coli and the hemolytic uremic syndrome in childhood.

Authors:  P C Rowe
Journal:  Can J Infect Dis       Date:  1995-03

2.  Evaluation of BBL CHROMagar O157 versus sorbitol-MacConkey medium for routine detection of Escherichia coli O157 in a centralized regional clinical microbiology laboratory.

Authors:  D L Church; D Emshey; H Semeniuk; T Lloyd; J D Pitout
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

3.  Verocytotoxin producing Escherichia coli.

Authors:  M G Brook; B A Bannister
Journal:  BMJ       Date:  1991-10-05

4.  A Canadian multicentre case-control study of sporadic Escherichia coli 0157:H7 infection.

Authors:  D Holton; J Wilson; A Ellis; D Haldane; N April; K Grimsrud; B Friesen; J Spika
Journal:  Can J Infect Dis       Date:  1999-03

5.  Detection of Escherichia coli O157:H7 and other intestinal pathogens in patients with diarrhoeal disease.

Authors:  W Baffone; G Ciaschini; A Pianetti; G Brandi; A Casaroli; F Bruscolini
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

6.  Cattle as a possible source of verocytotoxin-producing Escherichia coli O157 infections in man.

Authors:  P A Chapman; C A Siddons; D J Wright; P Norman; J Fox; E Crick
Journal:  Epidemiol Infect       Date:  1993-12       Impact factor: 2.451

7.  Survival and growth of Escherichia coli O157:H7 in ground, roasted beef as affected by pH, acidulants, and temperature.

Authors:  U M Abdul-Raouf; L R Beuchat; M S Ammar
Journal:  Appl Environ Microbiol       Date:  1993-08       Impact factor: 4.792

8.  Diarrhoea in close contacts as a risk factor for childhood haemolytic uraemic syndrome. The CPKDRC co-investigators.

Authors:  P C Rowe; E Orrbine; H Lior; G A Wells; P N McLaine
Journal:  Epidemiol Infect       Date:  1993-02       Impact factor: 2.451

9.  Occurrence and phenotypic properties of verotoxin producing Escherichia coli in sporadic cases of gastroenteritis.

Authors:  A P Burnens; P Boss; F Orskov; I Orskov; U B Schaad; F Müller; R Heinzle; J Nicolet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

10.  Epidemiology of Shiga toxin producing Escherichia coli in Australia, 2000-2010.

Authors:  Hassan Vally; Gillian Hall; Amalie Dyda; Jane Raupach; Katrina Knope; Barry Combs; Patricia Desmarchelier
Journal:  BMC Public Health       Date:  2012-01-21       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.